专利新颖性检查
- 作者仓库星标 11,320
- 作者仓库 Auto-claude-code-research-in-sleep
- 领域
- 工程开发
- 作者声明的智能体
- 未找到明确声明;不据此推断已兼容或已测试
- 静态检查
- 88 / 100 · 启发式扫描,不代表运行安全
- 运行环境证据
- 未执行;当前没有隔离运行测试证据
- 作者 / 版本 / 许可证
- @wanshuiyin · 未声明许可证
- 上下文用量评级
- 低消耗
- 接入复杂程度
- 即装即用
- 是否需要外部接口密钥
- 不需要
- 兼容的系统
- 未声明(默认跨平台)
- 运行环境要求
- 未检出明确要求
- 检测到的文件与系统行为
-
- 只读
- 允许写入 / 修改
- 网络行为
- 仅限本地
- 安装命令数
- 无(仅作为资料)
需要注意: 未声明工具权限范围;实际权限由运行环境决定。
第 1 步:定义权利要求要素
从发明描述中,提取定义发明范围的关键权利要求要素: 列出使发明具有新颖性的技术特征 识别哪些特征是从现有技术与发明中已知的 2-3 个独立权利要求的草案初步权利要求语言(方法 + 系统)
第 2 步:预期分析(新颖性)
对于每个初步权利要求,针对`PRIOR_ART_REPORT.md`中的每个现有技术参考进行测试: 单一参考测试:是否有任何单一参考公开了所有权利要求要素?权利要求要素 · 参考文献 1 · 参考文献 2 · 参考文献 3 · ... 特征 A · 是/否 + 证据 特征 B · 是/否 + 证据
第三步:显而易见性分析(创造性)
如果发明具有新颖性(通过步骤 2),则测试显而易见性: 两个/三个参考文献组合测试: 能否组合 2-3 个参考文献以使权利要求变得显而易见?对于顶级参考文献的每种组合: 主要参考文献:哪个参考文献最接近要求保护的发明?辅助参考文献:哪些参考文献教导了缺失的元素?
第4步:跨模型审查员验证
通过 `mcp__codex__codex` 以 xhigh 推理调用 `REVIEWER_MODEL`:
第 5 步:针对特定司法管辖区的评估
对于每个目标司法管辖区,提供专利性评估: 根据 35 USC 102/103(美国): 新颖性:通过/失败(如果失败,请引用具体参考文献) 非显而易见性:通过/失败(如果失败,请引用组合) 根据中国专利法(中国)第 22 条:
第6步:输出
写`patent/NOVELTY_ASSESSMENT.md`:
# Patent Novelty and Non-Obviousness Check
Assess patentability of: **$ARGUMENTS**
Adapted from `/novelty-check` for patent legal standards. Research novelty is NOT the same as patent novelty.
## Constants
- `REVIEWER_MODEL = gpt-5.5` — Model used via Codex MCP for cross-model examiner verification
- `NOVELTY_STANDARD = patent` — Always use legal patentability standard, not research contribution standard
## Inputs
1. Invention description from `$ARGUMENTS`
2. `patent/PRIOR_ART_REPORT.md` (output of `/prior-art-search`)
3. `patent/INVENTION_BRIEF.md` if exists
## Shared References
Load `../shared-references/patent-writing-principles.md` for novelty/non-obviousness standards.
Load `../shared-references/patent-format-us.md` for 102/103 analysis framework.
## Workflow
### Step 1: Define Claim Elements
From the invention description, extract the key claim elements that would define the invention's scope:
1. List the technical features that make the invention novel
2. Identify which features are known from prior art vs. inventive
3. Draft preliminary claim language for 2-3 independent claims (method + system)
### Step 2: Anticipation Analysis (Novelty)
For each preliminary claim, test against EACH prior art reference in `PRIOR_ART_REPORT.md`:
**Single-reference test**: Does any single reference disclose ALL claim elements?
| Claim Element | Ref 1 | Ref 2 | Ref 3 | ... |
|--------------|-------|-------|-------|-----|
| Feature A | Yes/No + evidence | | | |
| Feature B | Yes/No + evidence | | | |
| Feature C | Yes/No + evidence | | | |
| Feature D | Yes/No + evidence | | | |
**Verdict per reference**:
- ANTICIPATED: One reference discloses every element → claim is not novel
- NOT ANTICIPATED: At least one element missing from every single reference → claim is novel
### Step 3: Obviousness Analysis (Inventive Step)
If the invention is novel (passes Step 2), test for obviousness:
**Two/three-reference combination test**: Can 2-3 references be combined to render the claim obvious?
For each combination of the top references:
1. **Primary reference**: Which reference is closest to the claimed invention?
2. **Secondary reference(s)**: Which reference(s) teach the missing element(s)?
3. **Motivation to combine**: Would a POSITA have reason to combine these references?
- Explicit suggestion in the references themselves?
- Same field, same problem?
- Common design incentive?
- Known technique for improving similar devices?
Format as a matrix:
| Combination | Primary | Secondary | Missing Elements | Motivation to Combine | Obvious? |
|-------------|---------|-----------|-----------------|----------------------|----------|
| Ref1 + Ref2 | Ref1 | Ref2 | Feature D | Same field, similar problem | Yes/No |
### Step 4: Cross-Model Examiner Verification
Call `REVIEWER_MODEL` via `mcp__codex__codex` with xhigh reasoning:
```
mcp__codex__codex:
config: {"model_reasoning_effort": "xhigh"}
prompt: |
You are a senior patent examiner at the [USPTO/CNIPA/EPO].
Examine the following invention for patentability.
INVENTION: [invention description + preliminary claims]
PRIOR ART: [prior art references with key teachings]
Please analyze:
1. Anticipation (novelty): Does any single reference anticipate any claim?
2. Obviousness: Can any combination of references render claims obvious?
3. Claim scope: Are the claims broad enough to be valuable?
4. Recommended amendments if any claim is rejected.
Be rigorous and cite specific references.
```
### Step 5: Jurisdiction-Specific Assessment
For each target jurisdiction, provide a patentability assessment:
**Under 35 USC 102/103 (US)**:
- Novelty: PASS / FAIL (cite specific reference if fail)
- Non-obviousness: PASS / FAIL (cite combination if fail)
**Under Article 22 CN Patent Law (CN)**:
- 新颖性 (Novelty): 通过 / 未通过
- 创造性 (Inventive Step): 通过 / 未通过
**Under Article 54/56 EPC (EP)**:
- Novelty: PASS / FAIL
- Inventive step: PASS / FAIL (problem-solution approach)
### Step 6: Output
Write `patent/NOVELTY_ASSESSMENT.md`:
```markdown
## Patentability Assessment
### Invention Summary
[description]
### Overall Assessment
[PATENTABLE / PATENTABLE WITH AMENDMENTS / NOT PATENTABLE]
### Anticipation Analysis
[claim-by-claim matrix against each reference]
### Obviousness Analysis
[combination analysis with motivation to combine]
### Cross-Model Examiner Review
[summary of GPT-5.5 examiner feedback]
### Recommended Claim Amendments
[If claims need modification to overcome prior art, suggest specific amendments]
### Risk Factors
[What could cause rejection during actual prosecution?]
```
## Key Rules
- Patent novelty is absolute: any public disclosure before the priority date counts as prior art, worldwide.
- Research novelty ("has anyone published this?") is NOT the same as patent novelty ("does any single reference teach every claim element?").
- Obviousness requires BOTH: (1) a combination of references AND (2) a motivation to combine them.
- Never assume the invention is patentable just because no identical patent exists.
- The assessment is advisory only -- actual prosecution may reveal different prior art.
- If `mcp__codex__codex` is not available, skip cross-model examiner review and note it in the output.
章节与文件索引
按说明文件中的顺序排列。
常数
输入
共享参考文献
第 1 步:定义权利要求要素
第 2 步:预期分析(新颖性)
文件/命令 -> /novelty-check · REVIEWER_MODEL = gpt-5.5 · NOVELTY_STANDARD = patent · $ARGUMENTS · patent/PRIOR_ART_REPORT.md · /prior-art-search · patent/INVENTION_BRIEF.md · ../shared-references/patent-writing-principles.md
内容校验值 -> 20d4664407fc
当前原文的自动摘译,尚未人工审校。
常数
REVIEWER_MODEL = gpt-5.5— 通过 Codex MCP 用于跨模型审查员验证的模型NOVELTY_STANDARD = patent— 始终使用合法的专利性标准,而不是研究贡献标准输入
来自
$ARGUMENTS``patent/PRIOR_ART_REPORT.md的发明描述(/prior-art-search的输出)patent/INVENTION_BRIEF.md(如果存在)共享参考文献
加载
../shared-references/patent-writing-principles.md以获取新颖性/非显而易见性标准。加载 102/103 分析框架的../shared-references/patent-format-us.md。